Lanthanide and Asymmetric Catalyzed Syntheses of Sterically Hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones

Overview

Journal Tetrahedron Lett

Publisher Elsevier

Specialty Chemistry

Date 2016 Jan 20

PMID 26783372

Citations 4

Authors

Scott A Steiger

Chun Li

Charles F Campana

Nicholas R Natale

Affiliations

Soon will be listed here.

Citing Articles

Grignard Reagent Addition to Pyridinium Salts: A Catalytic Approach to Chiral 1,4-Dihydropyridines.

Somprasong S, Castineira Reis M, Harutyunyan S ACS Catal. 2024; 14(17):13030-13039.

PMID: 39263543 PMC: 11385375. DOI: 10.1021/acscatal.4c03520.

Synthesis, crystal structures, and Hirshfeld analysis of three hexa-hydro-quinoline derivatives.

Steiger S, Li C, Oliver A, Natale N Acta Crystallogr E Crystallogr Commun. 2022; 78(Pt 11):1089-1096.

PMID: 36380902 PMC: 9638977. DOI: 10.1107/S2056989022009495.

Synthesis and crystal structures of a bis-(3-hy-droxy-cyclo-hex-2-en-1-one) and two hexa-hydro-quinoline derivatives.

Steiger S, Li C, Gates C, Natale N Acta Crystallogr E Crystallogr Commun. 2020; 76(Pt 2):125-131.

PMID: 32071733 PMC: 7001840. DOI: 10.1107/S2056989019017018.

Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.

Steiger S, Li C, Backos D, Reigan P, Natale N Bioorg Med Chem. 2017; 25(12):3223-3234.

PMID: 28434782 PMC: 5813499. DOI: 10.1016/j.bmc.2017.04.008.

References

Jiang J, Yu J, Sun X, Rao Q, Gong L . Organocatalytic asymmetric three-component cyclization of cinnamaldehydes and primary amines with 1,3-dicarbonyl compounds: straightforward access to enantiomerically enriched dihydropyridines. Angew Chem Int Ed Engl. 2008; 47(13):2458-62. DOI: 10.1002/anie.200705300. View

Schade D, Lanier M, Willems E, Okolotowicz K, Bushway P, Wahlquist C . Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling. J Med Chem. 2012; 55(22):9946-57. PMC: 3518459. DOI: 10.1021/jm301144g. View

Natale N, Steiger S . 4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds. Future Med Chem. 2014; 6(8):923-43. DOI: 10.4155/fmc.14.46. View

Evans C, Jinwal U, Makley L, Dickey C, Gestwicki J . Identification of dihydropyridines that reduce cellular tau levels. Chem Commun (Camb). 2010; 47(1):529-31. PMC: 3251959. DOI: 10.1039/c0cc02253e. View

Natale N, Rogers M, STAPLES R, Triggle D, Rutledge A . Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships. J Med Chem. 1999; 42(16):3087-93. DOI: 10.1021/jm980439q. View

Dondoni A, Massi A . Decoration of dihydropyrimidine and dihydropyridine scaffolds with sugars via Biginelli and Hantzsch multicomponent reactions: an efficient entry to a collection of artificial nucleosides. Mol Divers. 2004; 6(3-4):261-70. DOI: 10.1023/b:modi.0000006806.91483.a3. View

Triggle D, Langs D, Janis R . Ca2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines. Med Res Rev. 1989; 9(2):123-80. DOI: 10.1002/med.2610090203. View

Hulubei V, Meikrantz S, Quincy D, Houle T, McKenna J, Rogers M . 4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter. Bioorg Med Chem. 2012; 20(22):6613-20. PMC: 3479305. DOI: 10.1016/j.bmc.2012.09.022. View

Zamponi G, Stotz S, Staples R, Andro T, Nelson J, Hulubei V . Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines. J Med Chem. 2002; 46(1):87-96. DOI: 10.1021/jm020354w. View

10.

Langle D, Marquardt V, Heider E, Vigante B, Duburs G, Luntena I . Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors. Eur J Med Chem. 2015; 95:249-66. DOI: 10.1016/j.ejmech.2015.03.027. View

11.

Evans C, Gestwicki J . Enantioselective organocatalytic Hantzsch synthesis of polyhydroquinolines. Org Lett. 2009; 11(14):2957-9. PMC: 2727599. DOI: 10.1021/ol901114f. View